Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2001
10/16/2001US6303611 For therapy of hyperalgesis
10/16/2001US6303610 Method of treating gout with certain indole compounds
10/16/2001US6303608 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
10/16/2001US6303606 Use of selective antagonists of the α1B-adrenergic receptor for improvement of sexual dysfunction
10/16/2001US6303603 3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors
10/16/2001US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease
10/16/2001US6303600 Substituted azabicyclic compounds
10/16/2001US6303542 Herbicidal 3-substituted-phenyl-1,2,3-benzotriazin-4-ones
10/16/2001US6303312 Modifying cell phenotype; medical research and therapy
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074815A2 Phenyl-substituted imidazopyridines
10/11/2001WO2001074814A1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands
10/11/2001WO2001074813A2 METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS
10/11/2001WO2001074810A2 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
10/11/2001WO2001074807A1 Indolylpyrrole derivatives and cell death inhibitors
10/11/2001WO2001074805A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001WO2001074791A1 Diazepane derivatives or salts thereof
10/11/2001WO2001074783A1 Cyclic lactams as inhibitors of a βετα protein production
10/11/2001WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001WO2001074773A2 Phenyl-substituted indoles as histamine h3-receptor antagonists
10/11/2001WO2001074771A1 Pyrrole-2,5-dione derivatives for the treatment of diabetes
10/11/2001WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001WO2001034572A3 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors
10/11/2001WO2001021585A3 Bis(1-aziridino-1-hydroxyiminomethyl)-derivatives, method for the production thereof and use thereof as anti-tumoral agents
10/11/2001WO2001019826A3 Triazolopyrimidine derivatives
10/11/2001CA2404592A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001CA2404023A1 Cyclic lactams as inhibitors of a.beta. protein production
10/11/2001CA2402705A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/10/2001EP1142882A1 Acrylonitrile compounds
10/10/2001EP1142872A1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/10/2001EP1140935A2 1,2-annelated quinoline derivatives
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140920A1 Piperidines as ccr5 modulators
10/10/2001EP1140918A1 Thrombin inhibitors
10/10/2001EP1140914A1 Non-peptide nk1 receptors antagonists
10/10/2001EP1140909A1 Novel inhibitors of farnesyl-protein transferase
10/10/2001EP1140908A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140907A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140902A1 Tricyclic farnesyl protein transferase inhibitors
10/10/2001EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
10/10/2001EP1140898A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
10/10/2001EP1140864A2 Vitronectin receptor antagonist pharmaceuticals
10/10/2001EP1140863A1 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140822A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140786A1 Reductive alkylation of secondary amines with hydrosilane
10/10/2001EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia
10/10/2001EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
10/10/2001EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
10/10/2001EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
10/10/2001EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia
10/10/2001EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
10/10/2001EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia
10/10/2001EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
10/10/2001EP1140095A1 (2-imidazoline-2-ylamino) quinoxaline derivatives for the treatment of pain
10/10/2001EP1140085A1 Azabicycloalkanes as ccr5 modulators
10/10/2001EP1140074A1 Indole and indolizidine derivatives for the treatment of migraine
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001EP0765320B1 Benzimidazolone derivatives with central dopaminergic activity
10/10/2001EP0759907B1 Substituted 3-phenylpyrazoles for use as herbicides
10/10/2001CN1316991A Azetidine derivatives, preparation and medicines containing them
10/10/2001CN1316426A Uracil compound and its appliance
10/10/2001CN1072669C Benzimidazole compounds and their use as modulators of the GABAA receptor complex
10/10/2001CN1072667C Mercaptoalkylpeptidyl compounds having imidzole substituent and their use as inhibitors of matrix metalluproteinass (MMP) and/or tumour necrosis factor (TNF)
10/10/2001CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/10/2001CN1072663C Novel benzoyl guanidine derivatives, process for their preparation and thier use in the preparation of medicines
10/10/2001CN1072647C Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
10/09/2001US6300363 Indole compounds as COX-2 inhibitors
10/09/2001US6300347 For therapy of tumor necrosis factor and interleukin-1 mediated diseases such as rheumatoid arthritis and diseases of bone metabolism, e.g. osteoporosis
10/09/2001US6300340 Useful for therapy of cancer and solid tumors
10/09/2001US6300338 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/09/2001US6300336 Method of treating or inhibiting functional disturbances or illnesses of the lower intestinal tracts, particularly abdominal visceral pain which accompanies them
10/09/2001US6300335 Urogenital disorders
10/09/2001CA2177147C 2-oxoindoline derivative
10/09/2001CA2119662C New nitrogen bicyclic derivatives, their preparation process and pharmaceutical compositions comtaining them
10/09/2001CA2018960C Salicylaldehyde derivatives and salicylic acid derivatives and their sulfur analogs, their preparation and their use as herbicides and bioregulators
10/04/2001WO2001072728A2 Novel piperazine derivatives
10/04/2001WO2001072721A2 Synergistic methods and compositions for treating cancer
10/04/2001WO2001072719A1 Method for producing asymmetrical 4,6-bis(aryloxy)pyrimidine derivatives
10/04/2001WO2001072717A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/04/2001WO2001072707A2 Carbamate caspase inhibitors and uses thereof
10/04/2001WO2001072705A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/04/2001WO2000034255A9 Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin
10/04/2001WO2000033836A9 5-membered heterocycles for the treatment of human diseases involving modulators of selectins
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010027196 Adenosine receptor ligands and their use in the treatment of disease
10/04/2001US20010027195 Indeno [1,2-c]pyrazol-4-ones and their uses
10/04/2001US20010027193 1-Diarylmethyl-4-alkyl or alkylsulfonylalkyl-azetidines; cannabinoid receptor antagonists; nervous system disorders (CNS); cardiovascular and glandular disorders; drug abuse; psychological disorders;
10/04/2001EP1137642A1 Bis-sulfonamides
10/04/2001EP0973395A4 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/04/2001EP0821685B1 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
10/04/2001EP0815105B1 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists
10/04/2001EP0563384B1 Uracil derivative
10/04/2001CA2404712A1 Synergistic methods and compositions for treating cancer comprising antiproliferative cytotoxic and cytostatic agents
10/04/2001CA2404626A1 Novel piperazine derivatives
10/04/2001CA2401242A1 Pharmaceutically active pyrrolidine derivatives
1 ... 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 ... 626